Increased expression of phosphorylated STAT3 and JAK/STAT activation in glioma samples has also been correlated with significantly shorter overall survival and has been associated with more aggressive tumors, indicating that STAT3 is a key contributor to glioma pathogenesis by mediating cell survival, growth, and proliferation [21–23]. This evidence concerns the gene STAT3 and central nervous system cancer.